author-photo

M. Dawson

University of Manchester

12

Papers

165

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

A phase 1 trial of intravenous 4‑(N‑(S‑glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours.

2013
Show All
- Source
- Cite
- Save
Citations (0)
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours

2013 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (27)
Statistical Considerations of Optimal Study Design for Human Plasma Proteomics and Biomarker Discovery.

2012 Journal of Proteome Research
Show All
- Source
- Cite
- Save
Citations (47)
Final results of a phase I clinical trial of the bioreductive drug RH1

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
An inducible caspase-3 "tumour death switch" model to identify circulating biomarkers of apoptotic cell death and test novel imaging probes for apoptosis

2007 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Phase I pharmacokinetic (PK) and pharmacodynamic (PD) trial of the bioreductive drug RH140

2005
Show All
- Source
- Cite
- Save
Citations (0)
453 Validation of pharmacodynamic assays to determine the clinical effect of an antisense to the XIAP inhibitor of apoptosis

2004 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
494 Preliminary results from a phase I clinical trial of the bioreductive drug, RH1

2004 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction technique

1998 Journal of Chromatography B: Biomedical Sciences and Applications
Show All
- Source
- Cite
- Save
Citations (10)
Patterns of Staphylococcus aureus colonization, toxin production, immunity and illness in burned children.

1994 Burns
Show All
- Source
- Cite
- Save
Citations (35)